Dr. Christopher S. O'Connell, MD

Dr. O'Connell practices at Skin Associates Of South Florida, P.a. in Coral Gables, Florida.

Dr. O'Connell's NPI, 1598934671, was assigned on February 22, 2008. Dr. O'Connell graduated from University of Miami, Miller School of Medicine in 2004. Dr. O'Connell holds Florida license ME100731.

Dr. O'Connell's primary practice is Skin Associates of South Florida, P.a., at 4425 Ponce De Leon Blvd Suite 200 Suite 200, Coral Gables, FL 33146-1871. The practice phone is (305) 443-6606.

Dr. O'Connell's primary practice is Skin Associates Of South Florida, P.a. in Coral Gables, Florida. The medical group on file is Skin Associates of South Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. O'Connell practices. Vendor and product names are available with a free account.

Procedural dermatology is Dr. O'Connell's primary specialty in the NPI Registry, under taxonomy code 207NS0135X. Dr. O'Connell is board certified in dermatology by the American Board of Dermatology. Dr. O'Connell is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and psoriasis among the conditions Dr. O'Connell treats.

CMS data shows 1,090 Medicare services from Dr. O'Connell across 8 procedure codes in 2024, for 228 Medicare patients. Medicare paid $49,297 for them. Every service was in an office.

CMS counts 228 Medicare patients who saw Dr. O'Connell in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. O'Connell's median patient age at 52, with 52% women.

In 2024, Dr. O'Connell wrote 203 Medicare Part D claims for 88 patients. 96% of them were for generic drugs. CMS names the drug for 107 of them, across 7 drugs with 11 or more claims each, at $2,192 in total drug cost. In 2023, CMS named 117 claims across 7 drugs.

Dr. O'Connell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 444 procedures of removal of skin lesions by Dr. O'Connell, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. O'Connell. Dr. O'Connell has published most often in J Drugs Dermatol. Dr. O'Connell's most frequent co-authors are Keyvan Nouri, MD, Benjamin A. Bassichis, MD and Noor M. Kassira, MD.

CMS Open Payments shows 450 general payments to Dr. O'Connell from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Galderma Laboratories, L.P. paid the most, $62,214. It also lists 6 research payments totaling $850 in 2025, naming 1 clinical trial.

Dmand AI lists 1 award for Dr. O'Connell.

Dr. O'Connell graduated from University of Miami, Miller School of Medicine in 2004. Dr. O'Connell is a member of AAD.

Dr. O'Connell is in network with 8 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.